ÀºÇòÅâÂÊ

ÀºÇòÅâÂÊ Services FAQ Contact Us 0
Home Pharmaceuticals Pain Management Drugs Market Size Projected to Grow at a CAGR of 3.5% by 2031
Pain Management Drugs Market

Pain Management Drugs Market Size, Share & Trends Analysis Report By Drug Class (NSAIDS, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, Nonnarcotic Analgesics), By Pain type (Chronic pain, Acute pain), By Indication (Arthritic Pain, Neuropathic Pain, Cancer Pain, Chronic Back Pain, Postoperative Pain, Migraine, Fibromyalgia, Bone fracture, Muscle sprain/strain, Acute appendicitis, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRPH54234DR
Author : ÀºÇòÅâÂÊ
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Pain Management Drugs Market Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. U.S.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Canada
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. U.K.
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Germany
    7. France
    8. Spain
    9. Italy
    10. Russia
    11. Nordic
    12. Benelux
    13. Rest of Europe
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. China
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Korea
    7. Japan
    8. India
    9. Australia
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. UAE
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Turkey
    7. Saudi Arabia
    8. South Africa
    9. Egypt
    10. Nigeria
    11. Rest of MEA
    1. Introduction
    2. By Drug Class
      1. Introduction
        1. Drug Class By Value
      2. NSAIDS
        1. By Value
      3. Anesthetics
        1. By Value
      4. Anticonvulsants
        1. By Value
      5. Antimigraine Agents
        1. By Value
      6. Antidepressants
        1. By Value
      7. Opioids
        1. By Value
      8. Nonnarcotic Analgesics
        1. By Value
    3. By Pain type
      1. Introduction
        1. Pain type By Value
      2. Chronic pain
        1. By Value
      3. Acute pain
        1. By Value
    4. By Indication
      1. Introduction
        1. Indication By Value
      2. Arthritic Pain
        1. By Value
      3. Neuropathic Pain
        1. By Value
      4. Cancer Pain
        1. By Value
      5. Chronic Back Pain
        1. By Value
      6. Postoperative Pain
        1. By Value
      7. Migraine
        1. By Value
      8. Fibromyalgia
        1. By Value
      9. Bone fracture
        1. By Value
      10. Muscle sprain/strain
        1. By Value
      11. Acute appendicitis
        1. By Value
      12. Others
        1. By Value
    5. Brazil
      1. By Drug Class
        1. Introduction
          1. Drug Class By Value
        2. NSAIDS
          1. By Value
        3. Anesthetics
          1. By Value
        4. Anticonvulsants
          1. By Value
        5. Antimigraine Agents
          1. By Value
        6. Antidepressants
          1. By Value
        7. Opioids
          1. By Value
        8. Nonnarcotic Analgesics
          1. By Value
      2. By Pain type
        1. Introduction
          1. Pain type By Value
        2. Chronic pain
          1. By Value
        3. Acute pain
          1. By Value
      3. By Indication
        1. Introduction
          1. Indication By Value
        2. Arthritic Pain
          1. By Value
        3. Neuropathic Pain
          1. By Value
        4. Cancer Pain
          1. By Value
        5. Chronic Back Pain
          1. By Value
        6. Postoperative Pain
          1. By Value
        7. Migraine
          1. By Value
        8. Fibromyalgia
          1. By Value
        9. Bone fracture
          1. By Value
        10. Muscle sprain/strain
          1. By Value
        11. Acute appendicitis
          1. By Value
        12. Others
          1. By Value
    6. Mexico
    7. Argentina
    8. Chile
    9. Colombia
    10. Rest of LATAM
    1. Pain Management Drugs Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Novartis AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Purdue Pharma L.P.
    3. Eli Lilly & Company
    4. Abbott Laboratories
    5. Endo Health Solutions Inc.
    6. Pfizer Inc.
    7. Mylan NV.
    8. Merck & Co. Inc.
    9. Johnson & Johnson
    10. GlaxoSmithKline Plc.
    11. Allergen Inc.
    12. Bayer AG
    13. Bristol-Myers Squibb
    14. Sorrento Therapeutics
    15. Valeant Pharmaceuticals International Inc.
    16. Boehringer Ingelheim
    17. WEX Pharmaceuticals
    18. Zynerba Pharmaceuticals
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
Airway Management Devices Market Size The global airway management devices market size was valued at USD 1.79 billion in 2024 and is projected to reach USD 1.88 billion in 2025 to USD 2.82 billion by 2033, registering a CAGR of 5.2% d
Buy Now
Global Report
API Management Market Size The global API management market size was valued at USD 2.11 billion in 2024 and is expected to grow from USD 2.58 billion in 2025 to reach USD 12.80 billion by 2033, growing at a CAGR of 22.15% during the forecast period
Buy Now
Global Report
The global casino management system market size was valued at USD 7.65 billion in 2023. It is estimated to reach USD 29.61 billion by 2032, growing at a CAGR of 13.12% during the forecast period (2024–2032). Advancements in technology, includin
Buy Now
Global Report
Pain Management Therapeutics Market Size The global pain management therapeutics market size was valued at USD 82.77 billion in 2024. It is anticipated to reach from USD 86.26 billion in 2025 to USD 120.07 billion by 2033, growing at a CAGR of 4.22%
Buy Now
Global Report
Parking Management Market Size The global parking management market size was valued at USD 5.60 billion in 2024 and is expected to grow from USD 6.20 billion in 2025 to reach USD 14.09 billion by 2033, growing at a CAGR of 10.8% during the forecast
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

ÀºÇòÅâÂÊ
© Copyright . All rights Reserved.